TANZISERTIB

TANZISERTIB : Inhibitor of JNK1, JNK2, JNK3

Structure

SERP Rating

Probe TANZISERTIB is in the process of SERP review.

Please continue to check back for new reviews and commentary.

Information

MAPK8
MAPK9
MAPK10

Inhibitor

up to 1 uM

In Vitro Validations

Uniprot ID: P45983

Target Class: Kinase

Target SubClass: CMGC

Potency: IC50

Potency Value: 61 ± 24 nM

Potency Assay: Biochemical assay

PDB ID for probe-target interaction (3D structure): 3TTI

Target aliases:

Mitogen-activated protein kinase 8, SAPK1C, SAPK1, ...

DOI Reference: 10.1016/j.bmcl.2011.12.027

Uniprot ID: P45983

Target Class: Kinase

Target SubClass: CMGC

Potency: Ki

Potency Value: 44 ± 3 nM

Potency Assay: Competitive binding assay

PDB ID for probe-target interaction (3D structure): 3TTI

Target aliases:

Mitogen-activated protein kinase 8, SAPK1C, SAPK1, ...

DOI Reference: 10.1016/j.bmcl.2011.12.027

In Cell Validations

In Vivo Data

Off-Target Selectivity Assesments

Potency assay (off target): Selective against MAP kinases ERK1 and p38α with IC50 of 0.48 and 3.4 μM respectively.

Potency assay (off target): Tanzisertib showed remarkable selectivity in a panel of 240 kinases, EGFR being the only non-MAP kinase inhibited more than 50% at 3 μM (IC50 = 0.38 μM). It inhibited no receptor at greater than 50% at 10 μM concentration in a panel of 75 receptors, ion channels and neurotransmitter transporters. Finally, when tested against 22 diverse non-kinase enzymes at 10 μM, no inhibition greater than 50% was observed.

I have extra information to add

SERP ratings and comments

No SERP comments found for TANZISERTIB